“A Phase I II Feasibility Study of Intravenous Cetuximab in Combination With 5 Days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES)”. Archives of Clinical and Biomedical Research 4, no. 4 (August 24, 2020): 394–412. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/acbr/article/view/14778.